A Randomized, Double-blind Trial Evaluating the Effects of Treatment With DFD-29 Capsules 40 mg QD in Comparison to Placebo on Microbial Flora in Healthy Adult Human Subjects, When Administered Over a Period of 16 Weeks
Latest Information Update: 23 Dec 2025
At a glance
- Drugs Minocycline (Primary)
- Indications Rosacea
- Focus Adverse reactions
- Sponsors Journey Medical Corporation
Most Recent Events
- 10 Dec 2025 According to a Journey Medical Corporation media release, data from this study were published in the Journal of Drugs in Dermatology.
- 10 Dec 2025 Results published in Journey Medical Corporation.
- 25 Oct 2024 Results presented at the Journey Medical Corporation in the Media Release.